Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Trujillo

Concepts (160)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
12
2024
119
4.400
Why?
Hypoglycemic Agents
21
2025
1212
4.000
Why?
Diabetes Mellitus, Type 2
22
2025
2428
3.520
Why?
Students, Pharmacy
10
2024
96
2.810
Why?
Glucagon-Like Peptide-1 Receptor
9
2022
91
2.720
Why?
Glucagon-Like Peptides
5
2020
49
1.920
Why?
Glucagon-Like Peptide 1
6
2018
112
1.610
Why?
Peptides
7
2018
910
1.490
Why?
Curriculum
9
2024
909
1.460
Why?
Receptors, Glucagon
3
2015
27
1.380
Why?
Insulin Glargine
4
2022
80
1.300
Why?
Hypoglycemia
6
2022
425
1.180
Why?
Educational Measurement
8
2019
257
1.170
Why?
Insulin
8
2022
2316
0.990
Why?
Blood Glucose
9
2020
2092
0.830
Why?
Osteoarthritis
1
2025
166
0.810
Why?
Teaching
2
2015
210
0.790
Why?
Liraglutide
4
2016
29
0.760
Why?
Immunoglobulin Fc Fragments
3
2020
40
0.750
Why?
Pharmacists
3
2019
246
0.720
Why?
Anti-Obesity Agents
3
2016
53
0.710
Why?
Glucagon
1
2020
105
0.640
Why?
Recombinant Fusion Proteins
3
2020
634
0.620
Why?
Metformin
2
2020
312
0.620
Why?
Emergency Treatment
1
2020
113
0.620
Why?
Weight Loss
7
2025
725
0.610
Why?
Medication Therapy Management
1
2019
72
0.590
Why?
Hyperglycemia
2
2014
326
0.580
Why?
Patient Education as Topic
4
2018
733
0.570
Why?
Societies, Pharmaceutical
2
2016
21
0.570
Why?
Gastrointestinal Diseases
1
2018
196
0.520
Why?
Schools, Pharmacy
3
2024
46
0.490
Why?
Education, Pharmacy, Graduate
2
2017
16
0.460
Why?
Humans
40
2025
128019
0.460
Why?
Drugs, Investigational
1
2014
32
0.460
Why?
Problem-Based Learning
2
2017
77
0.450
Why?
Drug Combinations
4
2018
323
0.430
Why?
Health Literacy
1
2015
161
0.410
Why?
Body Weight
4
2020
930
0.410
Why?
Peer Review
1
2012
47
0.380
Why?
Clinical Trials, Phase III as Topic
3
2022
92
0.380
Why?
Drug Administration Schedule
3
2020
755
0.380
Why?
Patient-Centered Care
1
2016
493
0.370
Why?
Learning
1
2015
393
0.350
Why?
Interpersonal Relations
1
2014
388
0.350
Why?
Pancreatitis
1
2010
128
0.310
Why?
Diet Records
1
2009
80
0.310
Why?
Faculty, Medical
1
2012
263
0.310
Why?
Cultural Competency
1
2009
81
0.300
Why?
Drug Interactions
1
2009
361
0.290
Why?
Cardiovascular Diseases
2
2017
1994
0.290
Why?
Attitude of Health Personnel
3
2015
1088
0.280
Why?
Communication
4
2016
838
0.280
Why?
Peer Group
1
2008
224
0.270
Why?
Empathy
1
2009
170
0.270
Why?
Diabetes Mellitus
2
2020
994
0.270
Why?
Clinical Protocols
1
2008
253
0.260
Why?
Clinical Trials as Topic
3
2020
997
0.260
Why?
Program Evaluation
3
2017
872
0.260
Why?
Obesity
2
2016
2859
0.250
Why?
Drug Therapy, Combination
2
2020
1012
0.230
Why?
Faculty, Pharmacy
1
2024
20
0.230
Why?
Spironolactone
1
2004
28
0.220
Why?
Drug Utilization Review
1
2004
57
0.220
Why?
Mineralocorticoid Receptor Antagonists
1
2004
45
0.220
Why?
Venoms
2
2015
28
0.220
Why?
Family Practice
1
2008
434
0.220
Why?
Gastric Inhibitory Polypeptide
1
2022
23
0.200
Why?
Injections, Subcutaneous
2
2014
145
0.190
Why?
Patient Compliance
1
2004
558
0.170
Why?
Administration, Intranasal
1
2020
82
0.170
Why?
Professional Role
2
2019
156
0.160
Why?
Delayed-Action Preparations
1
2020
170
0.160
Why?
Nausea
1
2020
108
0.160
Why?
Cardiovascular System
1
2020
136
0.150
Why?
Internship and Residency
1
2008
1043
0.150
Why?
Postprandial Period
1
2018
103
0.140
Why?
Insulin, Long-Acting
1
2017
61
0.140
Why?
Administration, Oral
1
2020
766
0.140
Why?
Health Knowledge, Attitudes, Practice
2
2016
1272
0.140
Why?
Commission on Professional and Hospital Activities
1
2017
3
0.140
Why?
Canagliflozin
1
2017
9
0.140
Why?
Treatment Outcome
3
2020
10110
0.140
Why?
Perception
1
2019
336
0.140
Why?
Glucosides
1
2017
38
0.130
Why?
Benzhydryl Compounds
1
2017
66
0.130
Why?
Professional Practice
1
2016
63
0.130
Why?
Self-Management
1
2018
161
0.120
Why?
Surveys and Questionnaires
3
2019
5353
0.120
Why?
Randomized Controlled Trials as Topic
2
2015
1356
0.120
Why?
Self Care
1
2018
368
0.120
Why?
Drug Approval
1
2015
86
0.120
Why?
Sitagliptin Phosphate
1
2015
31
0.120
Why?
Counseling
1
2018
382
0.120
Why?
United States Food and Drug Administration
1
2015
197
0.110
Why?
Pyrazines
1
2015
86
0.110
Why?
Disease Management
1
2018
583
0.110
Why?
Thiazolidinediones
1
2015
137
0.110
Why?
Triazoles
1
2015
150
0.110
Why?
Pilot Projects
2
2008
1559
0.100
Why?
Adult
6
2022
35176
0.100
Why?
Retrospective Studies
4
2022
14404
0.100
Why?
Comprehension
1
2014
165
0.100
Why?
Community Pharmacy Services
1
2012
43
0.100
Why?
Incidence
1
2018
2614
0.090
Why?
Educational Status
1
2014
470
0.090
Why?
Pharmacy Service, Hospital
1
2012
90
0.090
Why?
Feedback
1
2012
159
0.090
Why?
Algorithms
1
2019
1609
0.090
Why?
Male
7
2022
62757
0.090
Why?
Health Care Costs
3
2022
366
0.090
Why?
Heart Failure
1
2004
2141
0.090
Why?
Comorbidity
1
2015
1537
0.090
Why?
United States
3
2016
13785
0.090
Why?
Continuity of Patient Care
1
2012
275
0.080
Why?
Female
7
2022
68016
0.080
Why?
Clinical Competence
1
2016
1007
0.080
Why?
Patient Safety
1
2012
286
0.080
Why?
Data Collection
1
2012
645
0.080
Why?
Observer Variation
1
2008
310
0.070
Why?
Professional-Patient Relations
1
2009
139
0.070
Why?
Boston
1
2008
86
0.070
Why?
Advisory Committees
1
2008
214
0.070
Why?
Acute Disease
1
2010
961
0.070
Why?
Quality Assurance, Health Care
1
2008
315
0.060
Why?
Concurrent Review
1
2004
2
0.060
Why?
Hospitals, Teaching
1
2004
112
0.050
Why?
Massachusetts
1
2004
158
0.050
Why?
Guideline Adherence
1
2008
523
0.050
Why?
Hospitals, Urban
1
2004
129
0.050
Why?
Aged
4
2022
21892
0.050
Why?
Animals
1
2025
34487
0.050
Why?
Patient Care Team
1
2008
597
0.050
Why?
Reproducibility of Results
1
2008
3009
0.040
Why?
Hospitalization
1
2008
2057
0.040
Why?
Diabetes Mellitus, Type 1
1
2014
3625
0.040
Why?
Aged, 80 and over
2
2012
7029
0.040
Why?
Middle Aged
3
2012
30812
0.030
Why?
Analysis of Variance
1
2019
1266
0.030
Why?
Phentermine
1
2016
7
0.030
Why?
Bupropion
1
2016
40
0.030
Why?
Severity of Illness Index
1
2004
2703
0.030
Why?
Benzazepines
1
2016
40
0.030
Why?
Prospective Studies
1
2008
7035
0.030
Why?
Fructose
1
2016
106
0.030
Why?
Naltrexone
1
2016
84
0.030
Why?
Motivation
1
2019
544
0.030
Why?
Cough
1
2014
115
0.030
Why?
Forced Expiratory Volume
1
2014
509
0.030
Why?
Pharmacology, Clinical
1
2012
9
0.030
Why?
Administration, Inhalation
1
2014
661
0.030
Why?
Medication Reconciliation
1
2012
29
0.030
Why?
Health Personnel
1
2017
645
0.020
Why?
Medical Informatics
1
2012
99
0.020
Why?
Drug Monitoring
1
2012
190
0.020
Why?
Creatinine
1
2012
478
0.020
Why?
Colorado
1
2017
4369
0.020
Why?
Quality Improvement
1
2012
1093
0.010
Why?
Interprofessional Relations
1
2006
270
0.010
Why?
Cohort Studies
1
2012
5378
0.010
Why?
Trujillo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)